51.4% of Patients Would Consider Using GLP-1 Drugs Again 51.4% of participants said they would use GLP-1s again
For this reason, some GLP-1 manufacturers recommend using non-oral contraception for four weeks after starting or increasing tirzepatide to reduce the risk of unintended pregnancy
P., Brouwers, B., Wu, Q., Thomas, M
GLP-1 therapy may be appropriate for adults with: Treatment decisions should always be individualized after reviewing medical history, laboratory data, current medications, and overall health goals
Wyse is the visionary behind the International Linked Clinical Trials (LCT) program, which aims to prioritize potential disease-modifying compounds for Parkinsons treatment
Their primary concern is blood sugar destabilization